|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5 Pt 2
|
|
pubmed:dateCreated |
2003-5-9
|
|
pubmed:abstractText |
C-reactive protein has been measured in amniotic fluid in the second and third trimesters of gestation, and its elevated concentration has been found to be associated with adverse pregnancy outcome. It remains unexplained whether amniotic fluid C-reactive protein is of fetal origin.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
0029-7844
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
101
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1062-3
|
|
pubmed:dateRevised |
2009-10-26
|
|
pubmed:meshHeading |
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Evidence of fetal C-reactive protein urinary excretion in early gestation.
|
|
pubmed:affiliation |
Department of Obstetrics & Gynecology, University of Berne-Inselspital, Berne, Switzerland. luigi.raio@insel.ch
|
|
pubmed:publicationType |
Journal Article,
Case Reports
|
